Clinical trial
A Pilot Study of Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
NCT06546969 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- October 29, 2024
- Completion date
- December 31, 2028
- Enrollment
- 15 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
biliary tract cancer, cholangiocarcinoma